Merlin Nexus
North America, New York, United States, New York
Description
Merlin Nexus, based in New York, is a company focused on crossover private equity investing in the life sciences industry.
Investor Profile
Merlin Nexus has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series A, Series E rounds (top funding stages).
- Majority of deals are located in United States, Canada, United Kingdom.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
Stage Focus
- Post Ipo Equity (57%)
- Series A (29%)
- Series E (14%)
Country Focus
- United States (57%)
- Canada (29%)
- United Kingdom (14%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Pharmaceutical
- Medical
- Biopharma
- Oncology
- Genetics
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Merlin Nexus frequently co-invest with?
Which angels does Merlin Nexus often collaborate with?
What are some of recent deals done by Merlin Nexus?
Find More Investors Like Merlin Nexus
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
